The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
IL-6R/STAT3/miR-34a feedback loop promotes EMT-mediated colorectal cancer invasion and metastasis
Open accessAbstract
Members of the miR-34 family are induced by the tumor suppressor p53 and are known to inhibit epithelial-to-mesenchymal transition (EMT) and therefore presumably suppress the early phases of metastasis. Here, we determined that exposure of human colorectal cancer (CRC) cells to the cytokine IL-6 activates the oncogenic STAT3 transcription factor, which directly represses the MIR34A gene via a conserved STAT3-binding site in the first intron. Repression of MIR34A was required for IL-6-induced EMT and invasion. Furthermore, we identified the IL-6 receptor (IL-6R), which mediates IL-6-dependent STAT3 activation, as a conserved, direct miR-34a target. The resulting IL-6R/STAT3/miR-34a feedback loop was present in primary colorectal tumors as well as CRC, breast, and prostate cancer cell lines and associated with a mesenchymal phenotype. An active IL-6R/STAT3/miR-34a loop was necessary for EMT, invasion, and metastasis of CRC cell lines and was associated with nodal and distant metastasis in CRC patient samples. p53 activation in CRC cells interfered with IL-6-induced invasion and migration via miR-34a-dependent downregulation of IL6R expression. In Mir34a-deficient mice, colitis-associated intestinal tumors displayed upregulation of p-STAT3, IL-6R, and SNAIL and progressed to invasive carcinomas, which was not observed in WT animals. Collectively, our data indicate that p53-dependent expression of miR-34a suppresses tumor progression by inhibiting a IL-6R/STAT3/miR-34a feedback loop.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“IL-6 has been previously identified as a key cytokine that directly induces tumuor growth in CRC via STAT3 activation in IECs.12,15,46,47.”
From PU.1-driven Th9 Cells Promote Colorectal Cancer in Experimental Colitis Models Through Il-6 Effects in Intestinal Epithelial Cells (2022) · cites this paper as [47]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED AND REPLACED: microRNA involvement in human cancer
Iorio, M. V., & Croce, C. M. (2012) · Carcinogenesis · doi:10.1093/carcin/bgs140 · Cited by 577
RetractedA genetic model for colorectal tumorigenesis
Fearon, E. R., & Vogelstein, B. (1990) · Cell · doi:10.1016/0092-8674(90)90186-i · Cited by 12,132
Immunity, Inflammation, and Cancer
Grivennikov, S. I., Greten, F. R., & Karin, M. (2010) · Cell · doi:10.1016/j.cell.2010.01.025 · Cited by 10,755
Self-citationThe basics of epithelial-mesenchymal transition
Kalluri, R., & Weinberg, R. A. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39104 · Cited by 10,196
Epithelial-Mesenchymal Transitions in Development and Disease
Thiery, J. P., Acloque, H., Huang, R. Y. J., & Nieto, M. A. (2009) · Cell · doi:10.1016/j.cell.2009.11.007 · Cited by 9,931
Comprehensive molecular characterization of human colon and rectal cancer
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11252 · Cited by 8,499
STATs in cancer inflammation and immunity: a leading role for STAT3
Yu, H., Pardoll, D., & Jove, R. (2009) · Nature reviews. Cancer · doi:10.1038/nrc2734 · Cited by 4,383
Cancer Metastasis: Building a Framework
Gupta, G. P., & Massagué, J. (2006) · Cell · doi:10.1016/j.cell.2006.11.001 · Cited by 4,333
Regulatory networks defining EMT during cancer initiation and progression
Craene, B. D., & Berx, G. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3447 · Cited by 2,487
IKKβ Links Inflammation and Tumorigenesis in a Mouse Model of Colitis-Associated Cancer
Greten, F. R., Eckmann, L., Greten, T. F., Park, J. M., Li, Z.-W., Egan, L. J., Kagnoff, M. F., & Karin, M. (2004) · Cell · doi:10.1016/j.cell.2004.07.013 · Cited by 2,433
Self-citation
Research works printed but not linked: 1
- Jerry, 1993, Cancer Res., 53, 3374
Cited by
Sorted by citations
Items 401–500 of 754
One step ahead: miRNA-34 in colon cancer-future diagnostic and therapeutic tool?
Krajewska, J. B., Fichna, J., & Mosińska, P. (2018) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2018.09.006 · Cited by 23
Recent developments in targeting genes and pathways by RNAi‐based approaches in colorectal cancer
Jebelli, A., Baradaran, B., Mosafer, J., Baghbanzadeh, A., Mokhtarzadeh, A., & Tayebi, L. (2020) · Medicinal Research Reviews · doi:10.1002/med.21735 · Cited by 23
LncRNA LINC01116 Promotes the Development of Colorectal Cancer by Targeting miR-9-5p/STMN1
Bi, C., Cui, H., Fan, H., & Li, L. (2020) · OncoTargets and Therapy · doi:10.2147/ott.s253532 · Cited by 23
CYB5R1 links epithelial-mesenchymal transition and poor prognosis in colorectal cancer
Woischke, C., Blaj, C., Schmidt, E. M., Lamprecht, S., Engel, J., Hermeking, H., Kirchner, T., & Horst, D. A. (2016) · Oncotarget · doi:10.18632/oncotarget.8912 · Cited by 23
Self-citationChang, L., Fan, C., Tseng, W., Chein, H., Hsieh, T.-Y., Chen, J., Hwang, C., & Hua, C. (2016) · Disease Markers · doi:10.1155/2016/8143465 · Cited by 22
An antisense RNA capable of modulating the expression of the tumor suppressor microRNA-34a
Serviss, J. T., Andrews, N., den Eynden, J. V., Richter, F. C., Houtman, M., Vesterlund, M., Schwarzmueller, L., Johnsson, P., Larsson, E., Grandér, D., et al. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0777-5 · Cited by 21
Rašić, I., Rebić, V., Rašić, A., Akšamija, G., & Radović, S. (2018) · Journal of Oncology · doi:10.1155/2018/2830503 · Cited by 22
MicroRNAs Are Key Molecules Involved in the Gene Regulation Network of Colorectal Cancer
Yang, F., Xuan, G., Chen, Y., Cao, L., Zhao, M., Wang, C., & Chen, E. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.828128 · Cited by 22
Jain, S. M., Deka, D., Das, A., Paul, S., Pathak, S., & Banerjee, A. (2023) · Digestive Diseases and Sciences · doi:10.1007/s10620-023-07972-8 · Cited by 22
Circular RNAs function as competing endogenous RNAs in multiple types of cancer (Review)
Ji, Q., Zhang, C., Sun, X., & Li, Q. (2017) · Oncology Letters · doi:10.3892/ol.2017.7348 · Cited by 22
In-depth analysis of the critical genes and pathways in colorectal cancer
LIU, F., Ji, F., Yu-ling, J., Jiang, Y., Sun, X., Lu, Y., Zhang, L., Han, Y., & Liu, X.-S. (2015) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2015.2298 · Cited by 21
C1Q+ TPP1+ macrophages promote colon cancer progression through SETD8-driven p53 methylation
Veschi, V., Verona, F., Bella, S. D., Turdo, A., Gaggianesi, M., Franco, S. D., Mangiapane, L. R., Modica, C., Iacono, M. L., Bianca, P., et al. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02293-y · Cited by 23
miR-944 Suppresses EGF-Induced EMT in Colorectal Cancer Cells by Directly Targeting GATA6
Tang, J., Gao, W., Liu, G., Sheng, W., Zhou, J., Dong, Q., & Dong, M. (2021) · OncoTargets and Therapy · doi:10.2147/ott.s290567 · Cited by 21
Molecular and Metabolic Reprogramming: Pulling the Strings Toward Tumor Metastasis
Hipólito, A., Martins, F., Mendes, C., Lopes‐Coelho, F., & Serpa, J. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.656851 · Cited by 21
A Vicious Cycle: In Severe and Critically Ill COVID-19 Patients
Huang, P., Zuo, Q., Li, Y., Oduro, P. K., Tan, F., Wang, Y., Liu, X., Li, J., Wang, Q., Guo, F., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.930673 · Cited by 21
Han, Y., Fan, X., Fan, L., Wu, Y., Zhou, Z., Wang, G., Guo, L., Gao, W., Chen, Y., & Gao, Q. (2023) · Phytomedicine · doi:10.1016/j.phymed.2023.154672 · Cited by 23
Cracking the code: Deciphering the role of the tumor microenvironment in osteosarcoma metastasis
Jin, J., Cong, J., Lei, S., Zhang, Q., Zhong, X., Su, Y., Lu, M., Ma, Y., Li, Z., Wang, L., et al. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.110422 · Cited by 21
Fang, L., Zhang, L., Wang, M., He, Y., Yang, J., Huang, Z., Tan, Y., Fang, K., Li, J., Sun, Z., et al. (2024) · Cancer Research · doi:10.1158/0008-5472.can-23-1693 · Cited by 21
MicroRNAs as Therapeutic Targets and Colorectal Cancer Therapeutics
Yamamoto, H., & Mori, M. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-42059-2_13 · Cited by 21
Wang, J., Wang, X., Wang, Y., Li, S., & Wang, X. (2018) · Cancer Biology & Therapy · doi:10.1080/15384047.2018.1550570 · Cited by 21
Donnenberg, A. D., Luketich, J. D., & Donnenberg, V. S. (2019) · Oncotarget · doi:10.18632/oncotarget.27290 · Cited by 21
Wang, L., Wang, Y., Han, N., Wang, X., & Ruan, M. (2020) · Experimental Cell Research · doi:10.1016/j.yexcr.2020.112424 · Cited by 20
Zhang, K., Wang, D., Cai, H., Cao, M., Zhang, Y., Zhuang, P., & Shen, J. (2021) · Oncology Reports · doi:10.3892/or.2021.7926 · Cited by 20
Wang, C., Zou, Y., Pan, C., Shao, L., Ding, Z., Zhang, Y., Ye, J., Li, P., Ren, Y., & Zhu, C. (2021) · Annals of Translational Medicine · doi:10.21037/atm-20-1604 · Cited by 20
Yu, B., Zheng, L., Tang, H., Wang, W., & Lin, Y. (2021) · Molecular Medicine Reports · doi:10.3892/mmr.2021.12349 · Cited by 20
The Molecular Biology of Prostate Cancer Stem Cells: From the Past to the Future
Zhou, Y., Li, T., Jia, M., Dai, R., & Wang, R. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24087482 · Cited by 22
Iqbal, M. J., Javed, Z., Sadia, H., Mehmood, S., Akbar, A., Zahid, B., Nadeem, T., Roshan, S., Varoni, E. M., Iriti, M., et al. (2023) · Cancer Cell International · doi:10.1186/s12935-023-02929-3 · Cited by 22
Identification of key genes involved in JAK/STAT pathway in colorectal cancer
Yue, Y., Zhang, Q., Wu, S., Wang, S., Cui, C., Yu, M., & Sun, Z. (2020) · Molecular Immunology · doi:10.1016/j.molimm.2020.10.007 · Cited by 20
Xu, Y., Yuan, L., Jiang, X., Su, M., Huang, M., Chen, Y., Zhang, L., Chen, X., Zhu, H., & Lu, J. (2022) · MedComm · doi:10.1002/mco2.152 · Cited by 18
Targeting interleukin-6 as a treatment approach for peritoneal carcinomatosis
Dadgar, N., Sherry, C., Zimmerman, J., Park, H., Lewis, C. M., Donnenberg, A. D., Zaidi, A. H., Fan, Y., Xiao, K., Bartlett, D. L., et al. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05205-8 · Cited by 19
Molecular functions and significance of the MTA family in hormone-independent cancer
Ning, Z., Gan, J., Chen, C., Zhang, D., & Zhang, H. (2014) · Cancer and Metastasis Reviews · doi:10.1007/s10555-014-9517-1 · Cited by 20
CD126 and Targeted Therapy with Tocilizumab in Chronic Lymphocytic Leukemia
Liu, F., Jia, L., Wang, P., Farren, T., Li, H., Hao, X., & Agrawal, S. G. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-1139 · Cited by 19
Self-citationKumar, A. S., Jagadeeshan, S., Pitani, R. S., Ramshankar, V., Kesavan, V., Venkatraman, G., & Rayala, S. K. (2016) · Molecular and Cellular Biology · doi:10.1128/mcb.00510-16 · Cited by 19
Dravet-Gounot, P., Morin, C., Jacques, S., Dumont, F., Ely-Marius, F., Vaiman, D., Jarreau, P., Méhats, C., & Zana‐Taïeb, E. (2017) · PLoS ONE · doi:10.1371/journal.pone.0190445 · Cited by 19
Isoharringtonine inhibits breast cancer stem-like properties and STAT3 signaling
Chen, W., Wang, H., Cheng, M., Ni, L., Zou, L., Yang, Q., Cai, X., & Jiao, B. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.04.076 · Cited by 19
LPS promote Osteosarcoma invasion and migration through TLR4/HOTAIR
Wang, N., Meng, X., Liu, Y., Chen, Y., & Liang, Q. (2018) · Gene · doi:10.1016/j.gene.2018.09.031 · Cited by 19
LncRNA PAPAS may promote triple-negative breast cancer by downregulating miR-34a
Kong, Y., Geng, C., & Dong, Q. (2019) · Journal of International Medical Research · doi:10.1177/0300060519850724 · Cited by 19
Association of DCBLD2 upregulation with tumor progression and poor survival in colorectal cancer
He, J., Huang, H., Du, Y., Peng, D., Zhou, Y., Li, Y., Wang, H., Zhou, Y., & Nie, Y. (2020) · Cellular Oncology · doi:10.1007/s13402-020-00495-8 · Cited by 19
Mir34a constrains pancreatic carcinogenesis
Hidalgo‐Sastre, A., Lubeseder–Martellato, C., Engleitner, T., Steiger, K., Zhong, S., Desztics, J., Öllinger, R., Rad, R., Schmid, R. M., Hermeking, H., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-66561-1 · Cited by 19
Self-citationMicroRNA-148a-3p Directly Targets SERPINE1 to Suppress EMT-Mediated Colon Adenocarcinoma Progression
Hu, B., Chen, Z., Wang, X., Chen, F., Song, Z., & Cao, C. (2021) · Cancer Management and Research · doi:10.2147/cmar.s302777 · Cited by 19
Yan, X., Hong, B., Feng, J., Jin, Y., Chen, M., Li, F., & Qian, Y. (2022) · BMC Cancer · doi:10.1186/s12885-022-10159-5 · Cited by 19
Wang, Y., Xu, P., Yao, J., Yang, R., Shi, Z., Zhu, X., Feng, X., & Gao, S. (2015) · Targeted Oncology · doi:10.1007/s11523-015-0390-9 · Cited by 18
RetractedChen, P., Li, Y., Liu, R., Xie, Y., Jin, Y. T., Wang, M., Yu, Z., Wang, W., & Luo, X. (2022) · Translational Oncology · doi:10.1016/j.tranon.2022.101594 · Cited by 18
Helicobacter pylori–activated fibroblasts as a silent partner in gastric cancer development
Krzysiek-Mączka, G., Brzozowski, T., & Ptak‐Belowska, A. (2023) · Cancer and Metastasis Reviews · doi:10.1007/s10555-023-10122-1 · Cited by 20
The Role of MicroRNAs in Colorectal Cancer
Kim, S. W. (2017) · Korean Journal of Gastroenterology · doi:10.4166/kjg.2017.69.4.206 · Cited by 18
Zhou, J., Meng, Z., He, X., Cheng, D., Ye, H., Deng, X., & Chen, R. (2016) · Hepatology Research · doi:10.1111/hepr.12771 · Cited by 18
miR‐181c protects CsA‐induced renal damage and fibrosis through inhibiting EMT
Sun, W., Min, B., Du, D., Yang, F., Junping, M., Wang, W., Zhao, J., Tan, X., Li, Z., & Sun, J. (2017) · FEBS Letters · doi:10.1002/1873-3468.12872 · Cited by 18
Fawzy, M. S., Ibrahiem, A. T., Alsel, B. T. A., Alghamdi, S. A., & Toraih, E. A. (2020) · Scientific Reports · doi:10.1038/s41598-020-73951-y · Cited by 18
Metformin and Malignant Tumors: Not Over the Hill
Leng, W., Jiang, J., Chen, B., & Wu, Q. (2021) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s326378 · Cited by 19
Non-Coding RNA Networks in Pulmonary Hypertension
Zang, H., Zhang, Q., & Li, X. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.703860 · Cited by 18
Wang, Z., Wang, Q., Gong, L., Liu, T., Wang, P., Yuan, Z., & Wang, W. (2022) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2022.01.006 · Cited by 18
Bouznad, N., Rokavec, M., Öner, M. G., & Hermeking, H. (2023) · Cancers · doi:10.3390/cancers15041143 · Cited by 17
Self-citationEnhancing cancer therapy: The role of drug delivery systems in STAT3 inhibitor efficacy and safety
Wang, K., Zhou, K., Zhong, N., Cao, L., Li, Z., Xiao, Y., Wang, G.-R., Huo, F., Zhou, J., Liu, B., et al. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.122635 · Cited by 17
Cortes-Ballinas, L. G., López-Pérez, T. V., & Rocha‐Zavaleta, L. (2024) · Biomedical Reports · doi:10.3892/br.2024.1863 · Cited by 18
Identification of Key Genes in Colorectal Cancer Regulated by miR-34a
Wang, T., Xu, H., Liu, X., Chen, S., Zhou, Y., & Zhang, X. (2017) · Medical Science Monitor · doi:10.12659/msm.904937 · Cited by 17
Doukas, P. G., Vageli, D. P., Doukas, S. G., & Sasaki, C. T. (2019) · Oncotarget · doi:10.18632/oncotarget.26917 · Cited by 17
Liu, H., Lou, J., Liu, Y., Liu, Z., Xie, J., Sun, J., Pan, H., & Han, W. (2022) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2022.02.012 · Cited by 18
Lim, J.-H. (2014) · Korean Journal of Physiology and Pharmacology · doi:10.4196/kjpp.2014.18.5.391 · Cited by 17
MiRNAs as molecular biomarkers in stage II egyptian colorectal cancer patients
Bahnassy, A. A., Salem, S., El-Sayed, M., Khorshid, O., Abdellateif, M. S., Youssef, A. S. E.-D., Mohanad, M., Hussein, M. M., Zekri, A. N., & Allahloubi, N. M. A. (2018) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2018.09.002 · Cited by 17
Zhou, Y., Xia, Z., Cheng, Z., Xu, G., Yang, X., Liu, S., & Zhu, Y. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.005057 · Cited by 17
Mitsui, E., Kikuchi, S., Okura, T., Tazawa, H., Une, Y., Nishiwaki, N., Kuroda, S., Noma, K., Kagawa, S., Ohara, T., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-88033-0 · Cited by 16
Liver Extracellular Matrix in Colorectal Liver Metastasis
Morabito, M., Thibodot, P., Gigandet, A., Compagnon, P., Toso, C., Berishvili, E., Lacotte, S., & Peloso, A. (2025) · Cancers · doi:10.3390/cancers17060953 · Cited by 17
STAT3 Regulates miR-384 Transcription During Th17 Polarization
Han, J., Liu, Y., Zhen, F., Yuan, W., Zhang, W., Song, X., Dong, F., Yao, R., & Qu, X. (2019) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2019.00253 · Cited by 16
Ma, X., Yin, B., Guo, S., Umar, T., Liu, J., Wu, Z., Zhou, Q., Zahoor, A., & Deng, G. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/1744754 · Cited by 16
Tang-Fichaux, M., Branchu, P., Nougayrède, J., & Oswald, É. (2021) · Toxins · doi:10.3390/toxins13120897 · Cited by 18
The Role of Feedback Loops in Targeted Therapy for Pancreatic Cancer
Gu, W., Shen, H., Xie, L., Zhang, X., & Yang, J. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.800140 · Cited by 14
Liu, B., Su, F., Li, Y., Qi, X., Liu, X., Liang, W., You, K., Zhang, Y., & Zhang, J. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.01.133 · Cited by 16
Bao, Y., Zhang, S., Guo, Y., Wei, X., Zhang, Y., Yang, Y., Zhang, H., Ma, M., & Yang, W. (2018) · Clinical & Translational Oncology · doi:10.1007/s12094-018-1843-2 · Cited by 16
Circulating miR34a levels as a potential biomarker in the follow-up of Ewing sarcoma
Sciandra, M., Feo, A. D., Parra, A., Landuzzi, L., Lollini, P., Manara, M. C., Mattia, G., Pontecorvi, G., Baricordi, C., Guerzoni, C., et al. (2020) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-020-00567-2 · Cited by 16
Hu, B., Tang, W., Fan, J., Xu, Y., & Sun, H. (2017) · Oncology Letters · doi:10.3892/ol.2017.7349 · Cited by 16
The genetic script of metastasis
Jinesh, G. G., & Brohl, A. S. (2019) · Biological reviews/Biological reviews of the Cambridge Philosophical Society · doi:10.1111/brv.12562 · Cited by 16
Kim, S. J., García‐Recio, S., Creighton, C. J., Perou, C. M., & Rosen, J. M. (2019) · Oncogene · doi:10.1038/s41388-019-0852-0 · Cited by 16
Chrysin inhibits sphere formation in SMMC-7721 cells via modulation of SHP-1/STAT3 signaling pathway
Zhang, Y., Chen, F., Xiao, X., Pan, W., Yuan, Q., & Cao, J. (2019) · Cancer Management and Research · doi:10.2147/cmar.s193647 · Cited by 15
MicroRNA-34a deficiency leads to impaired wound closure by augmented inflammation in mice
Zhao, N., Wang, G., Long, S., Hu, M., Gao, J., Ran, X., Wang, J., Su, Y., & Wang, T. (2020) · Annals of Translational Medicine · doi:10.21037/atm.2020.03.161 · Cited by 15
Huang, Y., Chen, H., Hsu, Y., Chen, H.-C., Chuang, C.-H., Huang, S., & Hsu, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076650 · Cited by 15
Chen, Y., Guo, Y., Li, S., Xu, J., Zhao, C., Wang, J., Yang, J., Ning, W., Qu, Y., Zhang, M., et al. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.113315 · Cited by 15
Pharmacological and Immunological Targeting of Tumor Mesenchymalization
David, J., Dominguez, C. L., & Palena, C. (2016) · Pharmacology and Therapeutics · doi:10.1016/j.pharmthera.2016.11.011 · Cited by 14
Lin, W., Zou, H., Mo, J., Jin, C., Jiang, H., Yu, C., Jiang, Z., Yang, Y., He, B., & Wang, K. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.637878 · Cited by 15
Zhao, W., Wang, X., Jiang, Y., Jia, X., & Guo, Y. (2021) · Mammalian Genome · doi:10.1007/s00335-021-09874-4 · Cited by 15
RetractedNa+/H+-Exchanger Family as Novel Prognostic Biomarkers in Colorectal Cancer
Zhou, X., Jiang, M., Liu, Z., Xu, M., Chen, N., Wu, Z., Gu, C., Chin, E. Y., & Yang, X. (2021) · Journal of Oncology · doi:10.1155/2021/3241351 · Cited by 14
Golgi Phosphoprotein 3 Promotes Colon Cancer Cell Metastasis Through STAT3 and Integrin α3 Pathways
Huang, A., Wang, R., Cui, J., Gao, Y., Yin, Z., Chen, L., He, M., & Li, W. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.808152 · Cited by 15
Zhang, J., Ye, Y., Xu, Z., Luo, M., Wu, C., Zhang, Y., Lv, S., & Wei, Q. (2023) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2023.02.083 · Cited by 15
Cellular Senescence, a Novel Area of Investigation for Metastatic Diseases
Faggioli, F., Velarde, M. C., & Wiley, C. D. (2023) · Cells · doi:10.3390/cells12060860 · Cited by 15
Cancer Stem Cells are Regulated by STAT3 Signalling in Wilms Tumour
Liu, Y., Gao, X., Wang, S., Yuan, X., Pang, Y., Chen, J., & Wang, J. (2018) · Journal of Cancer · doi:10.7150/jca.23277 · Cited by 15
Cancer evolution: Special focus on the immune aspect of cancer
Hu, X., Chen, Z., Wang, Z., & Xiao, Q. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.05.006 · Cited by 14
He, J., Chen, S., Yu, T., Chen, W., Huang, J., Peng, C., & Ding, Y. (2022) · PubMed Central · Cited by 14
Non‐coding RNAs and colitis‐associated cancer: Mechanisms and clinical applications
Gu, Y., Zhao, H., Zheng, L., Zhou, C., Han, Y., Wu, A., Jia, Z., Xia, T., & Zhi, Q. (2023) · Clinical and Translational Medicine · doi:10.1002/ctm2.1253 · Cited by 14
Yu, J., Yang, H., Zhang, L., Ran, S., Shi, Q., Peng, P., Liu, Q., & Song, L. (2024) · BMC Gastroenterology · doi:10.1186/s12876-024-03195-x · Cited by 14
Fujimoto, T., Tamura, K., Nagayoshi, K., Mizuuchi, Y., Oh, Y., Nara, T., Matsumoto, H., Horioka, K., Shindo, K., Nakata, K., et al. (2024) · Surgery Today · doi:10.1007/s00595-024-02883-1 · Cited by 14
L‑fucose ameliorates the carcinogenic properties of Fusobacterium nucleatum in colorectal cancer
Duan, C., Tang, X., Wang, W., Qian, W., Fu, X., Deng, X., Han, C., & Hou, X. (2020) · Oncology Letters · doi:10.3892/ol.2020.12404 · Cited by 14
Gao, L., Hao, M., Liu, X., Zhang, L., Dong, Y., Zhang, Y., & He, X. (2021) · Journal of Ovarian Research · doi:10.1186/s13048-021-00913-x · Cited by 14
Xie, H., Zhao, Q., Yu, L., Lu, J., Peng, K., Xie, N., Ni, J., & Li, B. (2022) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2022.03.082 · Cited by 14
Wu, X., Chen, Z., Zeng, W., Zhong, Y., Liu, Q., & Wu, J. (2015) · BioMed Research International · doi:10.1155/2015/617316 · Cited by 15
The Role of Non-Coding RNAs in Autophagy During Carcinogenesis
de la Cruz‐Ojeda, P., Flores-Campos, R., Navarro‐Villarán, E., & Muntané, J. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.799392 · Cited by 14
The multifaceted role of microRNAs in colorectal cancer: pathogenesis and therapeutic implications
Longo, F., Gattuso, G., Spoto, G., Ricci, D., Vitale, A. C. V., Lavoro, A., Candido, S., Libra, M., & Falzone, L. (2025) · Non-coding RNA Research · doi:10.1016/j.ncrna.2025.05.012 · Cited by 17
Prognostic significance of osteosarcopenia in older adults with colorectal cancer
Takano, Y., Kodera, K., Tsukihara, S., Takahashi, S., Kobayashi, Y., Koyama, M., Kanno, H., Ishiyama, S., Saito, R., Hanyu, N., et al. (2023) · Annals of Gastroenterological Surgery · doi:10.1002/ags3.12663 · Cited by 13
Qi, Y., Wu, H., Zhu, T., Liu, Z., Liu, C., Yan, C., Wu, Z., Xu, Y., Bai, Y., Yang, L., et al. (2023) · Aging · doi:10.18632/aging.204967 · Cited by 13
Yu, J.-H., Tan, J.-N., Zhong, G., Zhong, L., Hou, D., Ma, S., Wang, P., Zhang, Z., Lu, X.-Q., Yang, B., et al. (2023) · Translational Oncology · doi:10.1016/j.tranon.2023.101823 · Cited by 13
König, J., Rokavec, M., Öner, M. G., Fei, Y., & Hermeking, H. (2024) · Cell Death and Differentiation · doi:10.1038/s41418-024-01380-9 · Cited by 13
Self-citationLiao, W.-R., Gu, C., Huang, A., Yao, J., & Sun, R. (2015) · Clinical & Translational Oncology · doi:10.1007/s12094-015-1388-6 · Cited by 13
Metadata
- Authors
- Rokavec, M., Öner, M. G., Li, H., Jackstadt, R., Jiang, L., Lodygin, D., Kaller, M., Horst, D., Ziegler, P. K., Schwitalla, S., Slotta-Huspenina, J., Bader, F. G., Greten, F. R., & Hermeking, H.
- Affiliations
- TUM Klinikum (DE)
- Pathologisches Institut (DE)
- Universitätsmedizin Göttingen (DE)
- German Cancer Research Center (DE)
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2014-03-18
- Volume
- 124
- Issue
- 4
- Pages
- 1853-1867
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC3973098
- OpenAlex
- W2104268053
- Cited by
- 753
- References
- 66
- Citations by year
- 2026: 17 · 2025: 29 · 2024: 60 · 2023: 66 · 2022: 90 · 2021: 69 · 2020: 66 · 2019: 76 · 2018: 59 · 2017: 69 · 2016: 65 · 2015: 66 · 2014: 20
- FWCI
- 23.51
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- mediaTUM (Technical University of Munich) (submittedVersion)
- GRO (submittedVersion)
- Funders
- Johns Hopkins University (HCT116)
- Deutsche Forschungsgemeinschaft
- Deutsche Krebshilfe
- Deutschen Konsortium für Translationale Krebsforschung
- FP7 Ideas: European Research Council (281967)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mechanisms of cancer metastasis
- Keywords
- colorectal cancer, epithelial-mesenchymal transition, interleukin-6, IL-6 receptor, STAT3, miR-34a, feedback loops, tumor invasion, metastasis, p53, snails, microRNA regulation
- MeSH terms
- Snail Family Transcription Factors, Animals, Disease Models, Animal, Female, Humans, Male, Neoplasm Invasiveness, Neoplasm Metastasis, Transcription Factors, Colorectal Neoplasms, Mice, Knockout, Receptors, Interleukin-6, Feedback, Physiological, MicroRNAs, Cell Line, Tumor, STAT3 Transcription Factor, Mice, Epithelial-Mesenchymal Transition
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review